Connect with us

Policy

CBD Oil Brand Recalled for High THC Level by Irish Government

mm

Published

on

Dutch CBD Brand Ordered to Recall

Dutch cannabinoid oil (CBD) brand EUPHORIA was found to have illegal levels of Tetrahydrocannabinol (THC) in the formulation, causing the Food Safety Authority of Ireland (FSAI) to recall their 10ml preparation labeled “Full Spectrum Oil extra strong 20%”.

Hemp and CBD products are legal as per the regulation of the Irish government; however, the formula should not contain THC of more than 0.2% to be viable for sale.

Said oil brand came from the Netherlands and has a best-before date of 31 August in 2020. Distributors and retailers alike are forced to submit to authority and remove the brand from their displays immediately.

CBD is gaining popularity all over the world and is a steadily growing industry due to respective laws being legislated in a number of countries. However, controversy still can’t escape it since it is closely linked to marijuana and THC, which have potent psychoactive elements that can induce drug dependency.

Cannabis Reception in Ireland

In Ireland, cannabis is still a huge topic for debate for supporters and critics. Some people still doubt its efficacy and the presence of side effects that may prove dangerous for a person’s health. The question mark that follows cannabis is heightened because of this recent turn of events.

The country authorized the sale and use of medical cannabis last 2016, but it was met with opposition from a group of medical practitioners. It’s also a hard feat for patients to acquire such since the government failed to retain a central supplier.

To reconcile their lack in implementation, the Ministry of Health headed by Simon Harris recently signed into legislation the 5-year Medical Cannabis Access Program. It aims to push for cannabis treatment when traditional methods fail, according to Harris.

This initiative is designed to legalize medical cannabis prescription made by doctors for various conditions like chemotherapy-sickness, epilepsy, and multiple sclerosis. Like any pharmaceutical product, patients can now present their Rx to drug stores and be given said medicine.

The program also involves the inventory-building of cannabis products, with Tilray being one of the international cannabis companies to successfully export their medical cannabis products to Ireland.

In relation to their first shipment, Tilray has pledged its commitment to providing for the subsequent demands of cannabis products once approved by the government. Their goal is to be the main supplier of the access program, enabling safe and reasonable access to medical cannabis

The company is currently at dialogue with the Irish authorities to shed some insight on the implementation of the newly penned program.

Unfortunately, Tilray failed to secure a spot in Italian cannabis export.

Cannabis in Neighboring Italy

Italy snubbed Tilray and two other international cannabis companies in favor of Aurora Cannabis (Canada) to fulfill the surprising shortage in production at the Florence facility. Italian Ministry of Defense further revealed that Tilray (Portugal) filed incorrect paper works and missed the set deadline, disqualifying them from the roster.

Albeit Italy’s willingness to pay for medical cannabis (the 400-kg cannabis deal cost them €569,000 (US$638,000), debates are also going over the country on whether low-THC “cannabis light” should be sold legally. The court ruled to ban the sale of such products, but enterprise owners fought back.

While it might be a phenomenal story to follow, Italians still appreciate cannabis products such as the CBD oil as an adjunct to medical treatments. Italy, including the Netherlands and Germany, are still the top three European countries with the strong medicinal cannabis industry.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Policy

New Poll Gets Public Support for FSA regulation on CBD

mm

Published

on

A recent YouGov poll issued by The Association for the Cannabinoid Industry or The ACI has shown overwhelming support regarding the UK’s Food and Standard Agency (FSA) guidance on cannabidiol regulation.

The ACI collaborated with YouGov to commission a poll that demonstrated strong public acceptance of the CBD regulation set forth by the FSA. The survey provided insight into the UK’s usage and awareness of CBD, revealing that 71% of the participants know about CBD, while 16% have bought a CBD product.

ACI Pharmacy Lead Dr. Andy Yates stated the YouGov poll revealed the public are aware of the current CBD regulation and are willing to support future developments by the FSA regarding new measures in the sale and use of the product.

The UK’s CBD regulation

The FSA conducted a review of various CBD products and discovered possible adverse effects on the health of a person consuming the said substance. It ordered businesses to disclose more information about their CBD products and what they contain. CBD businesses only have until March 31, 2021, to comply with the directive.

Advice on CBD safety for vulnerable groups was also given by the FSA, which includes pregnant women. These individuals are warned against taking CBD products. It also strongly suggested a daily limit of 70mg of CBD for healthy adults.

Asked about their level of support, the participants responded positively to the FSA’s decision. An overwhelming 74% of them welcome guidance, while only 8% are opposed to it.

There were 2065 respondents weighted to signify British adults 18 years and above.

However, CBD consumer confidence is a different story. Only 29% of participants are confident that cannabidiol products in the market are tested and labeled correctly. In comparison, 45% said they don’t wholly trust CBD products to have the right information and testing.

Legal & sustainable CBD

The Global CBD Summit is set to take place on March 16-17 in London, where The ACI will stand as a diamond sponsor.

The ACI Founder Steve Moore will be tackling about the association’s vision to make CBD legal and sustainable, which highlights consumer safety as a priority in his upcoming keynote address.

The ACI Regulatory Lead Dr. Parveen Bhatarah will then run a roundtable discussion that will talk about the association’s activities to make the vision a reality.

Dr. Bhatarah stated the regulatory clarity provided by The ACI’s recent statement would be the basis for a trustworthy and legal CBD sector in the UK. She mentioned the public’s positive reception of the FSA guidance denotes the need for leadership as the demand for CBD keeps rising.

CBD has been designated as a “novel food” since January 2019. It previously followed the EU guideline on Novel Food Regulations wherein food items without consumption history before May 1997 will be subjected to auditing before they can be marketed.

The Center for Medical Cannabis (CMC) trialed thirty CBD oil products in the UK. The tests revealed that more than one-third have only less than half of the claimed CBD content. One CBD oil did not have any cannabidiol at all.

Continue Reading

Policy

CBD Sellers Say New CBD Law Protects Consumers

mm

Published

on

Cannabidiol (CBD) sellers from Long Island believe that the new state law signed by Gov. Andrew M. Cuomo will defend consumers from dangerous products by aiding them in making informed choices and purchases.

Users laud CBD for being a therapeutic reliever for anxiety or pain without the psychoactive effect that its cousin marijuana causes.

The legislation passed last December require hemp businesses to test their products and label them appropriately. It also created a state-permitting process for hemp growers, processors, retailers and companies that are planning to sell hemp extracts and other hemp-related products like CBD.

CBD oil and cream are found by users to help in promoting sleep, aside from its alleged pain-relieving properties. However, there is little scientific research to back the claims made by consumers.

The new CBD state law

The newly signed measure allows the Department of Agriculture and Markets management over hemp cultivation, while the Department of Health has direct supervision over hemp extracts. The law will take effect on March 9, after 90 days following the signing of the bill last December 9.

The new legislation does not affect licensed hemp growers immediately. It also does not alter the state policy that prohibits the infusion of cannabidiol to food and beverages, according to a Department of Agriculture spokesperson.

Shop owner Jessica Naissant who sells locally manufactured CBD products like oils, soaps, lotions, and candles fully supports the new law. She believes that CBD is only a micro-dose of cannabis, which means that it does not cause a high that is a widely known effect of marijuana. She further stated that consumers need to know that the CBD products they buy are safe and from credible sources.

Naissant has the company’s products like topicals and oils independently verified by a third-party laboratory. Her shop only stocks CBD products that come with a certificate of analysis, which shows how much CBD is incorporated into the product.

The Food and Drug Administration (FDA) has given caution to buyers in September about CBD products that were falsely labeled and contained more or less of what the product claims to have. It was after the agency found out through tests conducted on several products sold in the market today.

Concerns from the market players

Despite the law, some market players worry that the cost of securing permits and tests will block small businesses from successfully entering the industry.

Cuomo’s office stated that the cost of securing state permits is not yet decided. In a statement made by the governor, the state is planning to hold a hemp summit to discuss priorities and policies regarding the CBD industry, which will likely happen in January.

CBD manufacturing company owner and CEO Craig Zaffe said that the law would benefit both sellers and consumers. Zaffe is also the owner of an online CBD retailer, CBDoilsofLongIsland.com. He stated that there are numerous cannabidiol products in the market, but many of them are falsely labeled. Some have misrepresented CBD levels.

Zaffe remarked that credible companies that take the time and effort to produce legitimate products that don’t cut corners are on the losing end of the current market condition. Consumers are also in danger of buying harmful CBD products because of no standard vets for product quality.

ACD Health and Wellness, Zaffe’s company, enlists Colorado-based Botanacor CBD testing laboratory for its products and commissions Oregon farms as its hemp source. Its customers can access lab reports upon request.

Zaffe believes that succeeding in the industry means caring for the people and being ahead of regulations.

Continue Reading

Policy

Former NBA Player Pushes for Lawful CBD Use in the League

mm

Published

on

CBD in the NBA

Al Harrington, a former NBA player, attended the Las Vegas MJBizCon, the biggest convention for US cannabis trade, expressed his firm belief that cannabis is a healthy medical option for professional athletes.

Advocates like Harrington have been pushing for leagues to allow cannabis use. As a response, Major League Baseball has recently announced that it will stop testing in the minor leagues for marijuana use.

Harrington’s CBD advocacy

Harrington is the founder of Viola, a cannabis company championing for the use of cannabis to alleviate pain, among other alleged therapeutic benefits. He stated that a player’s day-to-day pain management problems could be answered by cannabis.

He also added that the use of natural options is nowhere near dangerous compared to prescribed pain relievers and opioids after surgery, which are addictive.

Recreational marijuana is now lawful in 11 states, including D.C., and medical marijuana is allowed in 33 states. Harrington, a pro-marijuana advocate, trusts the less psychoactive cannabidiol or CBD will be easier to accept by the NBA.

Harrington along with co-founders Sanford Kunkel, ex-physician of the Indiana Pacers and Joe Abunassar, NBA trainer, established Harrington Wellness. The brand features hemp-derived CBD that has less than 0.3% of tetrahydrocannabinol or THC, the compound responsible for the high in marijuana.

Harrington believes that 90% of NBA players support cannabis and would be the backing they need to reach their goals. He relayed how cannabis helped him walk pain-free after undergoing 13 surgeries during his 16-year career. After retiring in 2014, he considered coaching but ultimately felt that founding a cannabis company was his calling.

An open secret

Michele Roberts, National Basketball Players Association executive director, sees a policy change in the league following the upcoming presidential elections. NBA Commissioner Adam Silver has also relayed the willingness of the league to reevaluate the ban after reviewing medical marijuana. The NBPA Anti-Drug Program currently bans CBD and other marijuana-related products.

Antonio Harvey, a former NBA player, reaffirms that players don’t use cannabis because of its addicting property. He said athletes typically use it to cope with pain from playing the sport. Harvey now has his cannabis company, Terra Mater Cannabis.

Harrington was introduced to CBD back in 2012 and later used THC, for which he was open about smoking weed up to his final career year. He even had a cannabis greenhouse in Denver.

Isaiah Thomas, a Wizards guard, stated that players using cannabis isn’t a secret even if he does not use it himself. He said that other players talk about using it all the time. Even GSW Coach Steve Kerr also claimed to have smoked marijuana two times for extreme back pain.

Harvey has already secured 17 endorsement commitments from other retired athletes for his edible THC-dosed product, Legend.

Moving forward

Harrington has been in talks with NBPA regarding a possible team-up with his cannabidiol brand. Roberts is aware of the trend and sees the league be more amenable to CBD, which does not violate federal laws.

Roberts stated that the league and NBPA are on the same page regarding the amendment of current rules on cannabis. There is no aversion, Roberts adds, but the need to eliminate the possibility of jeopardizing the players.

Then secretary-general Jeff Sessions rescinded a policy discouraging prosecutors from interfering in states where marijuana was legal. The impending threat from the Justice Department has shelved the talks in the league regarding the removal of the cannabis ban. Roberts pointed out that the decision to stop testing for marijuana might progress, but it will not be anytime soon.

Medical professionals acknowledge CBD as a pain management option other than opioids. The most recent fatal opioid overdose incident happened earlier this year when Tyler Skaggs, 27-year-old Los Angeles pitcher, died from oxycodone and fentanyl. CBD, on the other hand, is not addictive.

Peter Grinspoon, Harvard Medical School faculty associate and Doctor for Cannabis Regulation board member, stated how CBD should be allowed for athletes since it is a safe alternative than the “junk” the players typically use.

However, CBD is yet to be officially recognized by the FDA as a treatment for many health conditions.

Harrington still believes that the partnerships he builds with outspoken players from the four major leagues can change the sport and lives of the athletes.

Continue Reading

Trending